
Wybiclav 228.5 Oral Suspension
Marketer
Gettin Lifesciences Pvt. Ltd.
Salt Composition
Amoxycillin (200mg) + Clavulanic Acid (28.5mg)
Overview Wybiclav 228.5 Oral Suspension
Amoxicillin/clavulanate 228.5mg/5ml oral suspension combats bacterial infections affecting various areas, including the ears, nose, throat, chest, lungs, teeth, skin, and urinary system. Its effectiveness extends to bacteria resistant to other treatments, offering a solution for resistant tuberculosis. This medication can be administered with or without food, though ingestion with food enhances absorption and minimizes stomach discomfort. The prescribed dosage, typically two to three times daily, is determined by the infection's severity, type, and your child's weight and age. Adhere strictly to the prescribed dosage, timing, and method. If vomiting occurs within 30 minutes, allow your child to settle before readministering the dose; avoid doubling the dose if nearing the next scheduled time. Potential side effects, such as vomiting, diarrhea, nausea, abdominal pain, and allergic reactions, usually subside. However, persistent or bothersome side effects warrant immediate consultation with your child's physician. Provide a complete medical history, including allergies, heart conditions, blood disorders, birth defects, respiratory issues, lung abnormalities, gastrointestinal problems, skin conditions, liver impairment, and kidney dysfunction. This comprehensive information aids the physician in optimizing dosage and treatment.
Uses of Wybiclav 228.5 Oral Suspension
Combating Multi-Drug Resistant Tuberculosis and Bacterial Infections
Major Benefits of Wybiclav 228.5 Oral Suspension:
Administer this medication precisely as your physician prescribes, adhering to both dosage and treatment length. Always consult the product label for detailed instructions prior to ingestion. Use a measuring device for accurate dosing and take orally. Ensure thorough shaking before each use. Consume Wybiclav 228.5 Oral Suspension with food.
Common Side effects of Wybiclav 228.5 Oral Suspension:
- Abdominal pain
- Allergy
- Vomiting
- Nausea
- Diarrhea
- Mucocutaneous candidiasis
How to use Wybiclav 228.5 Oral Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Consult the product label for complete instructions prior to ingestion. Use a measuring device for accurate dispensing and take orally. Ensure thorough shaking before each use. Consume Wybiclav 228.5 Oral Suspension with food.
How Wybiclav 228.5 Oral Suspension works:
Amoxycillin/clavulanate potassium (Wybiclav 228.5mg/5ml Oral Suspension) is a dual-action antibiotic. This formulation combines amoxycillin, which disrupts bacterial cell wall synthesis, with clavulanic acid, a beta-lactamase inhibitor. Clavulanic acid neutralizes the enzyme beta-lactamase, often produced by bacteria resistant to amoxycillin alone, thus enhancing the amoxycillin's antibacterial effect. This synergistic action makes the combination highly effective against a wide range of infections.
SAFETY ADVICE
KidneyCAUTION
Caution is advised when prescribing Wybiclav 228.5 Oral Suspension to individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is recommended. Similarly, a lower dose is required for newborns and babies because their kidneys are not fully mature.
LiverCAUTION
Patients with hepatic impairment should use Wybiclav 228.5 Oral Suspension cautiously, potentially requiring dosage modification. Physician consultation is advised. Routine liver function tests are recommended during treatment.
What if you forget to take Wybiclav 228.5 Oral Suspension :
Remember to administer the omitted dose immediately upon recollection, unless your physician instructs differently. However, if the next dose is nearly due, forgo the missed one. Avoid doubling the dose to compensate, and consistently adhere to the recommended dosage regimen.
Facts to Know About Wybiclav 228.5 Oral Suspension
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
